Back

Can your connective tissue disease-associated PAH patients achieve similar outcomes to your idiopathic PAH patients?

28 August 2017 (13:15 - 13:30)
Organised by:
Congress Presentation Part of: Can you achieve more for your pulmonary arterial hypertension (PAH) patients? An expert review of key recent data with initial combination therapy Chronic pulmonary hypertension ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor John G Coghlan

Royal Free Hospital, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Introduction - Can you achieve more for your pulmonary arterial hypertension (PAH) patients? An expert review of key recent data with initial combination therapy.
Professor I. Lang (Vienna, AT)
Presentation thumbnail
Risk stratification in PAH: are any of our patients really "low risk"?
Professor I. Lang (Vienna, AT)
Presentation thumbnail
The importance of reducing hospitalisations in PAH.
Professor J. Vachiery (Brussels, BE)
Presentation thumbnail
Q&A - Can you achieve more for your PAH patients? An expert review of key recent data with initial combination therapy.
Professor I. Lang (Vienna, AT)

Access the full session

Session thumbnail
Can you achieve more for your pulmonary arterial hypertension (PAH) patients? An expert review of key recent data with initial combination therapy

The Event

Event poster

ESC Congress 2017

28 August 2017 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Outcomes associated with modern treatment paradigms in connective tissue disease (CTD)-associated pulmonary arterial hypertension (PAH): a meta-analysis of randomized controlled trials (RCTs)
1 September 2020
thumbnail
Webinar
What's new in the diagnosis and treatment of pulmonary hypertension, Part 2. Understanding specific aspects of congenital heart disease, chronic thromboembolic PH, and the patient's voice
20 December 2022
thumbnail
Congress Presentation
A novel causative gene variant, TNFRSF13B p.Gly76Ser, in patients with pulmonary arterial hypertension
1 September 2020
thumbnail
Congress Presentation
Right ventricular arterial coupling in PAH: idiopatic versus systemic sclerosis-associated pulmonary arterial hypertension
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources